Symbol
| EIF2AK4
| contributors: mct - updated : 31-08-2012
|
HGNC name
| eukaryotic translation initiation factor 2 alpha kinase 4
|
HGNC id
| 19687
|
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | | |
abrogation of EIF2AK4 expression significantly inhibited tumour growth | neurology | neurodegenerative | alzheimer | |
EIF2AK3, EIF2AK4 are potential therapeutic targets for treatment of individuals with Alzheimer disease |
| | | |
| Gcn2-/- mice exhibited an increase in protein carbonylation, a marker of oxidative stress, in response to a long-term (24 weeks) leucine-imbalanced diet (ED& | |
916;Leu) |
|
|
|
|